BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $274,000 | -64.2% | 4,268 | -55.1% | 0.01% | -44.4% |
| Q3 2020 | $765,000 | -26.8% | 9,508 | -26.1% | 0.02% | -48.6% |
| Q2 2020 | $1,045,000 | 0.0% | 12,870 | 0.0% | 0.04% | 0.0% |
| Q1 2020 | $1,045,000 | -2.6% | 12,870 | 0.0% | 0.04% | +20.7% |
| Q4 2019 | $1,073,000 | +28.7% | 12,870 | +34.9% | 0.03% | +222.2% |
| Q3 2019 | $834,000 | -28.7% | 9,540 | -33.2% | 0.01% | 0.0% |
| Q2 2019 | $1,170,000 | -8.5% | 14,271 | -9.3% | 0.01% | -69.0% |
| Q1 2019 | $1,279,000 | +151.3% | 15,730 | +103.5% | 0.03% | +222.2% |
| Q4 2018 | $509,000 | -64.2% | 7,730 | -58.1% | 0.01% | -55.0% |
| Q3 2018 | $1,421,000 | -69.7% | 18,430 | -70.9% | 0.02% | -69.7% |
| Q2 2018 | $4,684,000 | -11.1% | 63,430 | -21.7% | 0.07% | -13.2% |
| Q1 2018 | $5,268,000 | +0.6% | 81,003 | 0.0% | 0.08% | +11.8% |
| Q4 2017 | $5,236,000 | -3.0% | 81,003 | -5.8% | 0.07% | -29.9% |
| Q3 2017 | $5,397,000 | -5.1% | 86,003 | -8.4% | 0.10% | -41.2% |
| Q2 2017 | $5,685,000 | -42.9% | 93,903 | -51.0% | 0.16% | +47.3% |
| Q1 2017 | $9,948,000 | +134.0% | 191,806 | +100.0% | 0.11% | +4.7% |
| Q4 2016 | $4,252,000 | -12.0% | 95,903 | -5.5% | 0.11% | -14.4% |
| Q3 2016 | $4,832,000 | +24.5% | 101,503 | +18.3% | 0.12% | +25.0% |
| Q2 2016 | $3,880,000 | -45.0% | 85,803 | -50.0% | 0.10% | +6.4% |
| Q1 2016 | $7,050,000 | +2622.0% | 171,606 | +4534.2% | 0.09% | +1075.0% |
| Q2 2015 | $259,000 | -76.4% | 3,703 | -76.9% | 0.01% | -68.0% |
| Q1 2015 | $1,096,000 | -42.9% | 16,003 | -38.9% | 0.02% | -40.5% |
| Q4 2014 | $1,920,000 | -20.2% | 26,203 | -21.8% | 0.04% | -19.2% |
| Q3 2014 | $2,405,000 | +41.0% | 33,503 | +41.9% | 0.05% | +2.0% |
| Q2 2014 | $1,706,000 | -11.2% | 23,603 | -9.6% | 0.05% | -15.0% |
| Q1 2014 | $1,921,000 | +5.8% | 26,103 | 0.0% | 0.06% | -21.1% |
| Q4 2013 | $1,815,000 | -41.7% | 26,103 | -44.9% | 0.08% | -43.3% |
| Q3 2013 | $3,114,000 | +26.6% | 47,403 | +33.5% | 0.13% | +21.8% |
| Q2 2013 | $2,459,000 | – | 35,503 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |